Science Explorer Back to mapMap
Discussion
Researcher · Mochida Pharmaceutical (Japan) · Japan

Shoji Furusako

Shoji Furusako publishes mostly in Immunology, Hematology and Molecular Biology, on topics such as Sepsis Diagnosis and Treatment, Platelet Disorders and Treatments and Blood Coagulation and Thrombosis Mechanisms.

OpenAlex
World rank
#3,479,882
of 7,710,434 ranked researchers
Rank in Japan
#85,009
of 383,136
Works
27
Citations
985
Citations per work
36.5
h-index
13
i10-index 17Top 57% in Immunology
Shoji Furusako

What does Shoji Furusako research?

Shoji Furusako's work is mostly in Medicine (29%), Immunology and Microbiology (16%), Biochemistry, Genetics and Molecular Biology (11%).

Everything else: 12 works · 42.9% of their workHealth Sciences: 8 works · 29.2% of their workMedicine: 8 works · 29.2% of their workHematology: 3 works · 12.7% of their workSurgery: 2 works · 6.3% of their workEpidemiology: 1 works · 5.1% of their workPharmacology: 1 works · 5.1% of their workLife Sciences: 8 works · 27.9% of their workImmunology and Microbiology: 4 works · 16.5% of their workImmunology: 4 works · 16.5% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 11.4% of their workMolecular Biology: 3 works · 11.4% of their workTHEIR WORKShoji Furusako27works
Life Sciences28%Health Sciences29%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1242.9%
    1. Medicine829.2%
    1. Immunology and Microbiology416.5%
    2. Biochemistry, Genetics and Molecular Biology311.4%
  1. 1Immunology16% of their works
  2. 2Hematology13% of their works
  3. 3Molecular Biology11% of their works
  4. 4Surgery6% of their works
  5. 5Epidemiology5% of their works
  6. 6Pharmacology5% of their works

Research topics

Which keywords describe Shoji Furusako's research?

The keywords of their largest research topics: Inflammation, Hemostasis, Thrombosis, Epidemiology, Cancer, Immune Thrombocytopenic Purpura, Platelets and Protease-Activated Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Inflammation113 topics
  2. Hemostasis82 topics
  3. Thrombosis72 topics
  4. Epidemiology62 topics
  5. Cancer42 topics
  6. Immune Thrombocytopenic Purpura41 topic
  7. Platelets41 topic
  8. Protease-Activated Receptors41 topic
  9. Sepsis41 topic
  10. Septic Shock41 topic
  11. Thrombin41 topic
  12. Hereditary Angioedema31 topic
  13. Kinin Receptor Family31 topic
  14. Pattern Recognition Receptors31 topic
  15. Toll-like Receptors31 topic
  16. Amino Acid Transporters21 topic
  17. D-Serine21 topic
  18. Genetics21 topic
  19. Glycans21 topic
  20. Glycosylation21 topic
  21. Type 1 Diabetes21 topic

Where does Shoji Furusako work?

Shoji Furusako's main affiliation in the publication record is Mochida Pharmaceutical (Japan), Japan.

How many publications and citations does Shoji Furusako have?

OpenAlex counts 27 works and 985 citations for Shoji Furusako, an h-index of 13, ranking #3,479,882 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Shoji Furusako. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.